Plasma BNP and N‐terminal proBNP (NT‐proBNP) have become established biomarkers to facilitate the diagnosis and prognosis of heart failure (HF), and have been associated with cardiovascular morbidity and mortality in the general population.2 This evidence concerns the gene NPPB and hydrops fetalis.